Table 2.
Comparison of IF, ELISA and CBA NMO/AQP4-IgG detection rates [Number (%) of each group positive]
| Group | IF | ELISA (>5IU/ml) | CBA |
|---|---|---|---|
| 1: NMO (n=10) | 4 (40%) | 5 (50%) | 6 (60%) |
| 2:MS (n=5) | 0 | 0 | 0 |
| 3:Unclassified (n=16) | 5 (31%) | 11 (69%) | 13 (81%) |
Comparison of IF, ELISA and CBA NMO/AQP4-IgG detection rates [Number (%) of each group positive]
| Group | IF | ELISA (>5IU/ml) | CBA |
|---|---|---|---|
| 1: NMO (n=10) | 4 (40%) | 5 (50%) | 6 (60%) |
| 2:MS (n=5) | 0 | 0 | 0 |
| 3:Unclassified (n=16) | 5 (31%) | 11 (69%) | 13 (81%) |